Navigation Links
Focus on Paediatric TB

Paediatric TB is of concern as it is a reflection of the prevalence of sputum smear positive pulmonary tuberculosis and the extent of transmission of TB infection in the community. 6 to 8% of all new TB cases reported under the programme are of paediatric age group (0 to 14 years). In the year 2006, the percentage of paediatric cases reported at national level and Orissa State was 6% and 4% respectively.

As paediatric TB is a reflection of extent of transmission of TB infection in the community, detection and cure of adult tuberculosis will prevent the transmission of TB infection and hence reduce the burden of paediatric tuberculosis. Various steps taken under the programme to cut the chain of transmission and control of tuberculosis cases are:

To achieve and maintain a cure rate of 85% amongst new sputum positive cases and to detect and maintain a case detection rate of at least 70% amongst such cases.

Uninterrupted supply of quality drugs to patients in patient-wise boxes for the entire duration of treatment under direct observation (DOTS).

All children <6 yrs of age who are household contacts of smear positive TB cases are screened for TB and after excluding active tuberculosis are offered chemoprophylaxis using Isoniazid (INH) 5mg/kg body weight.

BCG vaccination is available under the Universal Immunization Programme (UIP) in the country which prevents severe form of TB in children.

Management of paediatric TB is one of the activities under Revised National Tuberculosis Control Programme.

This information was given by the Minister of State for Health & Family Welfare, Smt. Panabaka Lakshmi on 4th May, 2007 in a written reply to a question in the Rajya Sabha.


'"/>




Page: 1

Related medicine news :

1. Focus on DNA transcription
2. Focused Treatment For Childhood Cancer
3. Focussed treatment for Hodgkins disease
4. World Heart Day To Focus On Ideal Body Weight And Shape To Reduce Risk Of Heart Disease
5. Now Employers Focus On Employees Mental health
6. A New Focus For The Mechanism Of Nerve Growth
7. JRRD Focuses On Issues Such As Spinal Cord Injury and Prosthetics
8. UN research symposium To Focus on Open source and Open Medicine
9. Biocon To Shift Focus On Innovation To Accelerate Growth
10. UK Has To Focus On Bridging the Gap between Healthcare Professionals and Patients
11. The Australian Medical Association To Focus On Health Of Aborigines
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: